Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms

Completed

Conditions studied: Acute Asthma

In brief

The hypothesis to be tested is that acutely ill asthmatics who do not resolve their attacks following standard doses of albuterol and require admission to hospital have single nucleotide polymorphisms of their B2 adrenergic receptors that lower B2 agonist responsivity.

Key facts

Study ID

NCT01016444

Run by

MetroHealth Medical Center

People needed

311

Starts

2009-12-01

Expected to finish

2011-07-29

Last updated by the study team

2021-09-01

Who can join

Age: 16 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Acute asthma

You may not qualify if…

• Any other condition

Where it is running

• MetroHealth Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.